Menu
Recruiting NCT06657430

A Study on the Preference of Risperidone Dosage Forms

— Observational Schizophrenia Bipolar Affective Disorder Autism Spectrum Disorder Conduct Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Schizophrenia, Bipolar Affective Disorder, Autism Spectrum Disorder, Conduct Disorder. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.

Detailed description

This study aims to understand patients' needs and preferences for antipsychotic dosage forms and to clarify the clinical value of patch-form antipsychotics.

Primary outcome measures

  • Proportion of patients (and their caregivers) who prefer risperidone patch-form medicine [Time frame: "through study completion, an average of 6 months]
Secondary outcome measures (1)
  • Factors related to patients' preference for risperidone patch-form medicines [Time frame: through study completion, an average of 6 months]

Eligibility criteria

Inclusion criteria

  • Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.

Exclusion criteria

  • Have difficulty reading and understanding Chinese or refuse to participate in the study.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

China · 1 center
  • Shanghai Mental Health Center — Shanghai

Identifiers

NCT: NCT06657430 · 2024-85

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗